This inventor holds 26 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Synthesis. Top assignees: United Therapeutics Corporation, Lung Biotechnology Pbc, Lung Biotechnology Inc.. Active years: 2012-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
16 out of 133 
9 out of 20 
1 out of 2 Years Active: 2012-2023
Areas of Expertise:
Title: Sudersan M Tuladhar: Innovator in Prostacyclin Derivatives
Introduction
Sudersan M Tuladhar is a distinguished inventor based in Silver Spring, MD, who holds a remarkable portfolio of 26 patents. His work primarily focuses on the development and improvement of processes for synthesizing important pharmaceutical compounds, particularly prostacyclin derivatives.
Latest Patents
Among his latest innovations, Tuladhar is credited with a patent for a process to prepare treprostinil, the active ingredient in Remodulin®. This invention outlines an enhanced method for converting benzindene triol to treprostinil through the formation of salts of treprostinil, including a purification step for the compound. Another significant patent involves the synthesis of intermediates for producing prostacyclin derivatives. This process utilizes regioselective methods and highlights the use of microwave radiation to heat the compound at a temperature ranging from 180°C to 185°C, showcasing Tuladhar's innovative approach to pharmaceutical synthesis.
Career Highlights
Throughout his career, Sudersan M Tuladhar has made significant contributions to the field of pharmaceutical chemistry. He has applied his expertise while working with notable companies such as United Therapeutics Corporation and Lung Biotechnology PBC, where he has been instrumental in advancing drug development processes.
Collaborations
Working alongside esteemed colleagues, including Hitesh Batra and David A Walsh, Tuladhar has fostered collaborations that have enhanced his research and innovations. These partnerships reflect the collective effort needed to drive advancements in biotechnology and medicinal chemistry.
Conclusion
Sudersan M Tuladhar's contributions to the field of pharmaceuticals exemplify the spirit of innovation. His patents, combined with significant collaborations, continue to influence the development of critical treatments in medicine, particularly in the realm of prostacyclin derivatives. His dedication to improving pharmaceutical processes positions him as a leading figure in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile